Bausch Health Companies Inc. Number of Businesses Acquired
Bausch Health Companies Inc. (BHC) reported Number of Businesses Acquired of 0 business for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-19.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:NumberOfBusinessesAcquired · last filed 2020-02-19
- Bausch Health Companies Inc. number of businesses acquired for the quarter ending 2017-03-31 was 0.00 business.
- Bausch Health Companies Inc. number of businesses acquired for fiscal 2018 was 0.00 business.
- Bausch Health Companies Inc. number of businesses acquired for fiscal 2017 was 0.00 business.
- Bausch Health Companies Inc. number of businesses acquired for fiscal 2016 was 0.00 business.
| Period end | Number of Businesses Acquired 3 month | Number of Businesses Acquired 6 month | Number of Businesses Acquired 9 month | Number of Businesses Acquired 12 month | Number of Businesses Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | 0.00 business 10-K · filed 2020-02-19 | ||||
| 2017-12-31 | 0.00 business 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | 0.00 business 10-Q · filed 2017-11-07 | ||||
| 2017-06-30 | 0.00 business 10-Q · filed 2017-08-08 | ||||
| 2017-03-31 | 0.00 business 10-Q · filed 2017-05-09 | ||||
| 2016-12-31 | 0.00 business 10-K · filed 2019-02-20 | 1.00 business 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |